BG
FLXN

BlackRock Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BlackRock Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$59K Buy
+3,128
New +$59.8K ﹤0.01% 2896

Other funds holding FLXN

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

BlackRock Group's FLXN Position: Q4 2016 in Review

BlackRock Group opened a new position in Flexion Therapeutics, Inc. (FLXN) in Q4 2016: 3,128 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #2896 among its holdings.

94 funds tracked by Wall St. Rank hold FLXN as of Q4 2016.

  • BlackRock Group held 3,128 shares of Flexion Therapeutics, Inc. worth $59K as of Q4 2016.
  • Flexion Therapeutics, Inc. was a new BlackRock Group position in Q4 2016.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2896 holding.
  • 94 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.